Each member of the IL-12 family has been implicated in the development and severity of SLE in which the IL-12 and IL-23/Th17 axis are recognized therapeutic targets in the disease (4–6), and IL-27 is involved in the pathogenesis of SLE (7, 8). This evidence concerns the gene IL27 and systemic lupus erythematosus.